BRPI0514644A - composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna - Google Patents

composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna

Info

Publication number
BRPI0514644A
BRPI0514644A BRPI0514644-5A BRPI0514644A BRPI0514644A BR PI0514644 A BRPI0514644 A BR PI0514644A BR PI0514644 A BRPI0514644 A BR PI0514644A BR PI0514644 A BRPI0514644 A BR PI0514644A
Authority
BR
Brazil
Prior art keywords
rna
compound
phosphoramidite
ribonucleic acid
different
Prior art date
Application number
BRPI0514644-5A
Other languages
English (en)
Inventor
Tadaaki Ohgi
Kouichi Ishiyama
Yutaka Masutomi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of BRPI0514644A publication Critical patent/BRPI0514644A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/13Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/067Pyrimidine radicals with ribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

COMPOSTO FOSFORAMIDITA, COMPOSTO áCIDO RIBONUCLéICO, E MéTODO PARA PRODUZIR OLIGO-RNA A presente invenção é refere-se um composto fosforamidita novo e útil para a síntese de oligo-RNA Um composto fosforamidita representado pela seguinte fórmula geral (1), em que: Bx representa uma nucleobase que pode ter um grupo protetor; e R¬ ¬ é um substituinte representado pela seguinte fórmula geral em que: R¬ ¬ , R¬ ¬ e R¬ ¬ são iguais ou diferentes e cada um representa hidrogênio ou alcóxi; e R¬ [¬ e R¬ 2b¬ são iguais ou diferentes e cada um representa alquila, ou R¬ [¬ e R¬ 2b¬ tomados juntos com o átomo de nitrogênio adjacente podem formar um grupo amino cíclico saturado de 5 a 6 membros, o grupo amino cíclico tendo opcionalmente um átomo de oxigênio ou de enxofre como um membro componente do anel, além do átomo de nitrogênio adjacente; e WG¬ ¬ e WG¬ ¬ são iguais ou diferentes e cada um representa um grupo captador de elétrons.
BRPI0514644-5A 2004-08-26 2005-08-25 composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna BRPI0514644A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004246185 2004-08-26
JP2005110817 2005-04-07
JP2005193313 2005-07-01
PCT/JP2005/015420 WO2006022323A1 (ja) 2004-08-26 2005-08-25 ホスホロアミダイト化合物及びオリゴrnaの製法

Publications (1)

Publication Number Publication Date
BRPI0514644A true BRPI0514644A (pt) 2008-06-17

Family

ID=35967530

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514644-5A BRPI0514644A (pt) 2004-08-26 2005-08-25 composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna

Country Status (12)

Country Link
US (1) US8691970B2 (pt)
EP (1) EP1795536B1 (pt)
JP (1) JP5157168B2 (pt)
KR (1) KR101281836B1 (pt)
CN (1) CN101048423B (pt)
AT (1) ATE556085T1 (pt)
AU (1) AU2005275801B2 (pt)
BR (1) BRPI0514644A (pt)
CA (1) CA2577922C (pt)
ES (1) ES2386709T3 (pt)
MX (1) MX2007002245A (pt)
WO (1) WO2006022323A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158775B2 (en) * 2006-02-27 2012-04-17 Nippon Shinyaku Co., Ltd. Method for detaching protecting group on nucleic acid
JPWO2007097447A1 (ja) * 2006-02-27 2009-07-16 日本新薬株式会社 核酸保護基の脱離方法
KR101405632B1 (ko) * 2006-08-02 2014-06-10 니뽄 신야쿠 가부시키가이샤 핵산 보호기의 도입 방법
JP2008174524A (ja) * 2007-01-22 2008-07-31 Nippon Shinyaku Co Ltd リボ核酸化合物の製造方法
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
RU2612521C2 (ru) 2009-07-06 2017-03-09 Онтории, Инк. Новые пролекарства нуклеиновых кислот и способы их применения
ES2586683T3 (es) * 2009-09-16 2016-10-18 Wave Life Sciences Japan, Inc. Grupo protector novedoso para sintetizar ARN y derivados del mismo
JP5847700B2 (ja) * 2010-03-05 2016-01-27 株式会社Wave Life Sciences Japan リボヌクレオシドホスホロチオエートの製造方法
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
JP6093924B2 (ja) * 2010-11-30 2017-03-15 株式会社Wave Life Sciences Japan 2’−o−修飾rna
CN103796657B (zh) 2011-07-19 2017-07-11 波涛生命科学有限公司 合成官能化核酸的方法
MX370398B (es) * 2011-08-25 2019-12-11 Bonac Corp Compuesto de glicosido, metodo para producir tioeter, eter, metodo para producir eter, metodo para producir un compuesto de glicosido, metodo para producir acido nucleico.
KR102213609B1 (ko) 2012-07-13 2021-02-08 웨이브 라이프 사이언시스 리미티드 키랄 제어
PL2872485T3 (pl) 2012-07-13 2021-05-31 Wave Life Sciences Ltd. Asymetryczna grupa pomocnicza
CA2879066C (en) 2012-07-13 2019-08-13 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
JP6571663B2 (ja) * 2013-09-14 2019-09-04 ケムジーンズ コーポレーション 逆方向アプローチを使用した長いrnaの非常に効果的な合成
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
CN104211741B (zh) * 2014-09-05 2017-05-31 河南师范大学 一种氘代核苷亚磷酰胺单体的合成方法
WO2017111137A1 (ja) 2015-12-22 2017-06-29 味の素株式会社 オリゴヌクレオチドの製造方法
KR102670605B1 (ko) * 2018-04-24 2024-05-29 스미또모 가가꾸 가부시끼가이샤 아미다이트 화합물 및 그 화합물을 사용한 폴리뉴클레오티드의 제조 방법
US12173028B2 (en) 2018-09-07 2024-12-24 Sumitomo Chemical Company, Limited Method for producing glycoside compound
JP7640461B2 (ja) 2019-10-11 2025-03-05 住友化学株式会社 核酸オリゴマーの製造方法
EP4047004B1 (en) * 2019-10-18 2024-03-06 FUJIFILM Wako Pure Chemical Corporation Phosphoramidite activator
WO2021079617A1 (ja) 2019-10-23 2021-04-29 住友化学株式会社 配糖体化合物、アミダイト化合物、およびこれら化合物を用いたポリヌクレオチドの製造方法
JP7667788B2 (ja) * 2020-01-29 2025-04-23 住友化学株式会社 核酸オリゴマーの製造方法
EP4098655A4 (en) 2020-01-29 2024-02-28 Sumitomo Chemical Company, Limited METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS
EP4130018A4 (en) 2020-03-27 2024-04-17 Sumitomo Chemical Company, Limited METHOD FOR PRODUCING A NUCLEIC ACID OLIGOMER
DK4137500T3 (da) 2020-04-14 2026-04-20 Sumitomo Chemical Co Fremgangsmåde til fremstilling af nukleinsyreoligomer
CN115397831B (zh) 2020-04-14 2026-02-24 住友化学株式会社 包含核酸寡聚物的组合物
CN115867559A (zh) * 2020-07-09 2023-03-28 住友化学株式会社 核酸寡聚物的制造方法
KR20230074205A (ko) 2020-09-24 2023-05-26 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
EP4368627A4 (en) 2021-07-06 2025-10-08 Sumitomo Chemical Co COMPOSITION CONTAINING A NUCLEIC ACID OLIGOMER
CN117980285A (zh) 2021-09-28 2024-05-03 住友化学株式会社 纯化二氯乙酸的制造方法
EP4474388A4 (en) * 2022-02-04 2025-10-01 Nitto Denko Corp PROCESS FOR PRODUCING OLIGONUCLEOTIDE
EP4474387A4 (en) 2022-02-04 2025-09-24 Nitto Denko Corp PROCESS FOR PRODUCING OLIGONUCLEOTIDE
US12509485B2 (en) 2022-03-23 2025-12-30 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomer
EP4559925A1 (en) 2022-07-22 2025-05-28 Sumitomo Chemical Company, Limited Production method of oligonucleotide
JPWO2024024873A1 (pt) 2022-07-28 2024-02-01
CN115010769B (zh) * 2022-08-04 2022-11-15 上海百力格生物技术有限公司 固相亚磷酰胺三酯法合成长链rna核酸的方法
WO2024089953A1 (ja) 2022-10-27 2024-05-02 住友化学株式会社 オリゴヌクレオチドの製造方法
JPWO2024143276A1 (pt) 2022-12-26 2024-07-04
CN119264195B (zh) * 2024-12-12 2025-04-08 天津奥瑞芙生物医药有限公司 一种亚磷酰胺单体的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956500A (en) 1973-04-03 1976-05-11 Union Carbide Corporation Carbamate pesticidal compositions
US4629814A (en) * 1985-08-27 1986-12-16 Rohm And Haas Company Process for preparing bis-bromoalkyl ethers
US4925856A (en) * 1987-07-28 1990-05-15 Sri International Aldoxime-substituted imidazolium derivatives useful in the treatment of poisoning by phosphorus-containing chemicals
JP2794461B2 (ja) 1989-08-17 1998-09-03 有機合成薬品工業株式会社 ホスホアミダイト化合物及びそれを用いたオリゴリボヌクレオチドの固相合成法
GB9126355D0 (en) 1991-12-11 1992-02-12 Ici Plc Production of hydrofluorocarbons
US5637776A (en) 1992-12-10 1997-06-10 Imperial Chemical Industries Plc Production of hydrofluorocarbons
AR037328A1 (es) 2001-10-23 2004-11-03 Dow Agrosciences Llc Compuesto de [7-bencil-2,6-dioxo-1,5-dioxonan-3-il]-4-metoxipiridin-2-carboxamida, composicion que lo comprende y metodo que lo utiliza

Also Published As

Publication number Publication date
JP5157168B2 (ja) 2013-03-06
EP1795536A1 (en) 2007-06-13
ATE556085T1 (de) 2012-05-15
ES2386709T3 (es) 2012-08-27
JPWO2006022323A1 (ja) 2008-05-08
CA2577922C (en) 2013-06-25
AU2005275801A2 (en) 2006-03-02
AU2005275801B2 (en) 2012-05-10
EP1795536A4 (en) 2009-04-08
CN101048423B (zh) 2011-06-08
EP1795536B1 (en) 2012-05-02
US8691970B2 (en) 2014-04-08
CN101048423A (zh) 2007-10-03
WO2006022323A1 (ja) 2006-03-02
KR20070054688A (ko) 2007-05-29
CA2577922A1 (en) 2006-03-02
KR101281836B1 (ko) 2013-07-03
US20070282097A1 (en) 2007-12-06
AU2005275801A1 (en) 2006-03-02
MX2007002245A (es) 2007-04-20

Similar Documents

Publication Publication Date Title
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
DK1740584T5 (da) Kondenseret chinolinderivat og anvendelse deraf
EA200970171A1 (ru) Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
EA201070874A1 (ru) Производные индол-2-карбоксамидов и азаиндол-2-карбоксамидов, замещённых силанильной группой, их получение и применение в терапии
BR122019003178B1 (pt) método de controle de pestes
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
BRPI0510598A (pt) compostos de amida de aril ou heteroaril substituìdos
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
BR112012007411A2 (pt) composto, processo para sua preparação e composição farmacêutica contendo o mesmo
AR049401A1 (es) Aza-biciclononanos
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
EP1634874A4 (en) imidazolidine
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
BR0315800A (pt) Derivados de imidazopiridina, seu processo de preparação e as composições farmacêuticas que os contêm
CR9472A (es) Derivados de aminoacidos
BR0310033A (pt) Inibidores da transcriptase reversa de não-nucleosìdeo
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
AR050250A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica
DK1831239T3 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde
DK1970372T3 (da) Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
BRPI0516192A (pt) composto, e, método para a preparação de um composto
TW200606588A (en) Resist composition and process for forming resist pattern
AR056805A1 (es) Un proceso para oxidacion para la preparcion de n- (3- amino-1- ( ciclobutilmetil) -2,3- dioxopropil ) -3-(n-(( ter-butilamino) carbonil )-3- metil- l- valil) -6,6- dimetil-3- azabiciclo (3.1.0) hexano -2- carboxamida y compuestos ralacionados
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]